Los Angeles, August 7, 2012 –Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians, today announced that Kerry Weems has joined the company’s board of directors. A nationally respected expert in health policy and government finance, Weems has served with distinction in the field of health care, including nearly 28 years in the Federal government, most recently as Acting Administrator of the Centers for Medicare and Medicaid Services (CMS) and as Vice-Chairman of the American Health Continue reading →
Los Angeles, July 17, 2012 –Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians, pharmacies and skilled nursing facilities, today issued the following letter to shareholders from its Chairman and Chief Executive Officer and Chief Scientific Officer, William Shell, M.D. Dear Fellow Shareholders: If one word can best characterize the past year for me and for Targeted Medical Pharma, that word would be change. It has been a fast-paced journey for all of us, marked by substantial Continue reading →
Expert Panel of Doctors to Discuss Clinical Data on Safety and Efficacy of Medical Foods in Pain Management and Sleep Disorders Los Angeles, June 19, 2012 – Physician Therapeutics, Inc., a division of Targeted Medical Pharma, Inc., will host a live webcast and conference call titled “Medical Foods in Clinical Practice,” to be held on Friday, June 29, starting at noon PST. Media, physicians, clinicians and other medical industry personnel interested in the safety and efficacy of medical foods in pain management and sleep disorders Continue reading →
Los Angeles, June 11, 2012 – Physician Therapeutics, Inc., a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and distributes specialty pharmaceuticals to physicians, pharmacies and skilled nursing facilities, published results from a clinical trial of the company’s proprietary medical food Theramine®. The trial demonstrated improvement in chronic low back pain in 129 subjects when administered as a standalone therapy or in conjunction with low dose naproxen for 28 days. The results of this study have been published in the March Continue reading →
Los Angeles, May 2, 2012 – Physician Therapeutics, Inc., a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that manufactures and distributes specialty pharmaceuticals to physicians, pharmacies and skilled nursing facilities, published results from a clinical trial of the proprietary medical food Sentra PM. This trial demonstrated improved sleep latency and improved nighttime parasympathetic nervous system activity as a standalone medication or used in conjunction with a low dose of Trazadone. The results of this study have been published in the May issue Continue reading →
Physician Therapeutics, a division of Targeted Medical Pharma Inc. will be exhibiting at the Freedom and Recovery, Integrated Mental Health and Addiction Treatment Conference for serivce memebers and first responders, April 23-26, 2012 at the Hotel del Coronado in San Diego, CA. The exhibit will feature updated clinical data regarding the nutritional management of PTSD and Gulf War Illness as well multimodal nonaddicitive treatment options for pain syndromes.
Los Angeles, CA, November 14, 2011 Targeted Medical Pharma Inc. which develops and sells medical food products through its subsidiary Physician Therapeutics, exhibited product information and technology related to its medical foods addressing pain management and sleep disorders related to Post Traumatic Stress Disorder to over 2000 active and retired United States Military pharmacists, service men and women at the Joint Forces Pharmacy Seminar in Dallas, Texas from October 31-November 3, 2011. Other exhibitors included Takeda, Teva Neuroscience, Pfizer, GlaxoSmithKilne, Endo Pharmaceuticals and Express Scripts. About Targeted Medical Pharma, Inc. Targeted Medical Continue reading →
Grants Cover Theramine® , Sentra PM®, Sentra AM® and GABAdone® Los Angeles, CA, Nov. 1, 2010 /Targeted Medical Pharma Inc. a Specialty Pharma company developing proprietary medical food products distributed through subsidiary Physician Therapeutics announced it has been awarded $733,429.00 in government grants. Under the recently enacted Patient Protection and Affordable Care Act, cash grants were awarded to Qualifying Therapeutic Discovery Projects that showed significant potential in producing new and cost-saving therapies, support job growth and increase U.S. competitiveness. Grants were awarded through a competitive Continue reading →
Read article “Double-Blind Clinical Trial of Theramine Published in the American Journal of Therapeutics” here.
In January of 2009 Physician Therapeutics, a wholly owned subsidiary of Targeted Medical Pharma Inc., initiated A Double Blind randomized controlled trial of single dose Naproxen and an amino acid Medical Food Theramine for the treatment of low back pain. Using 10 national sites over a 28 day period, this study consisted of 127 patients with established back pain. The trial concluded in June of 2009, and the study will be published by the American Journal of Therapeutics in November 2010.